Showing results (261-270 of 350) with videos related to

Sort By:
Pageof 35
Plos One|January 7, 2014
Riociguat reduces infarct size and post-infarct heart failure in mouse hearts: insights from MRI/PET imagingCarmen Methner, Guido Buonincontri, Chou-Hui Hu, et al.
The Journal of Biological Chemistry|May 14, 2010
Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclaseFaye Martin, Padmamalini Baskaran, Xiaolei Ma, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 23, 2011
Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertensionMarc Chester, Gregory Seedorf, Pierre Tourneux, et al.
The Journal of Clinical Investigation|August 1, 1995
Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertensionW Siffert, D Rosskopf, A Moritz, et al.
Bioorganic & Medicinal Chemistry|April 9, 2002
Metabolites of orally active NO-independent pyrazolopyridine stimulators of soluble guanylate cyclaseAlexander Straub, Jordi Benet-Buckholz, Rita Fröde, et al.
Molecular Pharmacology|August 24, 2007
Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivoChristiane Rothkegel, Peter M Schmidt, Derek-John Atkins, et al.
International Journal of Cardiology|March 5, 2004
Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathyHarald Lapp, Guido Boerrigter, Lisa C Costello-Boerrigter, et al.
The Journal of Sexual Medicine|September 20, 2012
Analysis of erectile responses to BAY 41-8543 and muscarinic receptor stimulation in the ratGeorge F Lasker, Edward A Pankey, Alexander V Allain, et al.
Pageof 35